Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseases

Article ID	Journal	Published Year	Pages	File Type
11009991	ClÃnica e InvestigaciÃ³n en Arteriosclerosis (English Edition)	2018	12 Pages	PDF

Abstract

Las prevalencias crudas más elevadas se detectaron en tabaquismo, inactividad fÃsica, obesidad, prediabetes, diabetes, hipertensión, dislipidemias y sÃndrome metabólico. Para valorar la verdadera dimensión epidemiológica de estas enfermedades y FRCV, es necesario realizar un análisis pormenorizado de tasas de prevalencia estratificadas por grupos etarios y de las tasas de prevalencia ajustadas por edad y sexo.

Keywords

AHA NCEP ACR IQR HDL-C ICD-9 CVR KDIGO CHD CVA CDA LDL-C ALT FPG HbA1c WHtR ATPIII EGFR IDF Glycosylated haemoglobin A1c AIP MetSyn GGT HTG CVRF HTN VLDL-C SBP NHLBI DBP CKD-EPI Hypertriglyceridaemia AST Aspartate aminotransferase Alanine aminotransferase albumin/creatinine ratio Systematic Coronary Risk Evaluation UAE American Diabetes Association Canadian Diabetes Association American Heart Association standard deviation National Cholesterol Education Program Peripheral arterial disease coronary heart disease cardiovascular disease Enfermedad cardiovascular Chronic obstructive pulmonary disease COPD chronic kidney disease kidney disease: improving global outcomes Cardiovascular risk Urinary albumin excretion International Diabetes Federation Diabetes mellitus Dislipidemia ine CVD Síndrome metabólico Metabolic syndrome Atherogenic index of plasma body mass index BMI Prevalencia Prevalence International Classification of Diseases International Classification of Primary Care Risk factors Factores de riesgo Cardiovascular risk factors 95% confidence interval Hypertension diastolic blood pressure systolic blood pressure National Heart, Lung, and Blood Institute Fasting plasma glucose high-density lipoprotein cholesterol interquartile range Insulin resistance CKD Waist-to-height ratio odds-ratio Score Chronic Kidney Disease Epidemiology Collaboration ADA PAD Adult Treatment Panel III total cholesterol Very low-density lipoprotein cholesterol Low-density lipoprotein cholesterol Gamma-glutamyl transferase